0.97
Neurocrine Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
1.45
FY23:
1.61
FY24:
1.72
FY25:
2.52
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.10
FY22:
0.92
FY23:
1.64
FY24:
1.99
FY25:
2.11
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.07
FY22:
2.37
FY23:
3.25
FY24:
3.72
FY25:
4.63
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.25
FY22:
0.54
FY23:
0.65
FY24:
0.51
FY25:
0.74
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.12
FY23:
0.36
FY24:
0.62
FY25:
0.64
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.37
FY22:
1.71
FY23:
2.23
FY24:
2.59
FY25:
3.25
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.07
FY22:
2.37
FY23:
3.25
FY24:
3.72
FY25:
4.63
All amounts in billions USD